Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
10/2004
10/07/2004US20040197863 for use as anticancer/tumor agents using real-time polymerase chain reaction genetic engineering
10/07/2004US20040197853 largely reduced of antigenicity compared to native trichosanthin (TCS), while retaining anti-tumor, anti-virus, abortifacient, and ribosome-inactivating protein activities; for treating leukemia
10/07/2004US20040197847 High throughput screening assays using fatty acid synthetic enzymes
10/07/2004CA2519707A1 Prostaglandin compositions for the treatment of erectile dysfunction
10/07/2004CA2517828A1 Compositions and methods for treatment of premature ejaculation
10/06/2004EP1463817A2 Histamine receptor h3 polynucleotides
10/06/2004EP1463804A1 Improved gamete recruitment and developmental competence in mammals by inhibiting the de novo sterol biosynthesis and/or promoting sterol efflux
10/06/2004EP1463758A2 Mammal prolactin variants
10/06/2004EP1463756A2 Secreted proteins
10/06/2004EP1463728A2 Fused cyclic modulators of nuclear hormone receptor function
10/06/2004EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists
10/06/2004EP1463707A2 A group of novel anti-cancer compounds with specific structure
10/06/2004EP1463525A2 Compositions and methods for the diagnosis and treatment of tumor
10/06/2004EP1463508A1 Selective dopamine d3 receptor agonists for the treatment of sexual dysfunction
10/06/2004EP1463493A1 Methods of inducing ovulation-using a non-polypeptide camp level modulator
10/06/2004EP1296981B1 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/06/2004EP1232141B1 Ethers of o-desmethyl venlafaxine
10/06/2004EP0917466B1 Oral contraceptive
10/06/2004EP0840608B1 Orotate salts of 5-amino or substituted amino 1,2,3-triazoles for treatment of neoplasms
10/06/2004CN1535312A PUFA polyketide synthase systems and uses thereof
10/06/2004CN1535274A Antidepressant (SSSRI) azaheterocyclymethyl derivatives of 7,8-dihydro-3H-6, 9-dioxa-1,3-diazacyclopenta[A] naphthalene
10/06/2004CN1535273A Novel 2,5-diazabicyclo [2.2.1] heptane derivatives
10/06/2004CN1535168A Controlled release composition and method of producing the same
10/06/2004CN1535141A Sustained-release composition and process for producing the same
10/06/2004CN1533799A Chinese medicinal tablet for treating gynecopathy and its preparation process
10/06/2004CN1533791A Chinese medicine scented tea
10/06/2004CN1533786A Blood quickening statis transforming plaster
10/06/2004CN1533782A Preparation method of dairy cattle mammitis anhinflammation powder
10/06/2004CN1533771A Medicine possessing menacme accerant contraception action
10/06/2004CN1533762A Bionic skin and vagine nursing liquid
10/06/2004CN1169824C Polytype gene of MXA protein and application thereof
10/06/2004CN1169789C Aminoalkoxy carbazoles for treatment of CNS diseases
10/06/2004CN1169571C Capsule for curing asynodia, spermatorrhea, nephralgia and osphyalgia
10/06/2004CN1169569C Composite medicine for treating mastoplasia and its preparing process
10/06/2004CN1169534C Medicine for curing impotence
10/06/2004CN1169529C Nano silver antimicrobial inflammation-relieving gel for curing prostatitis and its industrial production process
10/05/2004US6800632 Bicyclic inhibitors of glycogen synthase kinase 3
10/05/2004US6800627 Central nervous system, cardiovascular and gastrointestinal disorders, diabetes inspidus, sleep apnea
10/05/2004US6800625 For therapy of sexual dysfunction
10/05/2004CA2128956C Tricyclic diazepine vasopressin antagonists
09/2004
09/30/2004WO2004083209A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
09/30/2004WO2004083208A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
09/30/2004WO2004083199A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
09/30/2004WO2004083198A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators
09/30/2004WO2004083184A1 Receptor antagonist
09/30/2004WO2004082686A2 Use of compounds with combined 5-ht1a and ssri activities to treat sexual dysfunction
09/30/2004WO2003080105A9 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
09/30/2004WO2003068197A8 Method for systemic drug delivery through the nail
09/30/2004US20040192886 for use in the treatment and prevention of nervous system, epileptic, pain and vision defects; neuromuscular blocking agents; local anesthetic ; analgesics; neuroprotective agents
09/30/2004US20040192774 Method for improving the well-being of poultry by in-ovo injection of carnitine
09/30/2004US20040192750 Antiproliferative agents; anticancer agents; neurodegenerative agents sexual disorders; antidiabetic agents; urogenital disorders; antidiabetic agents; obesity; muscular disorders; aftertreatment surgery; autoimmune disease
09/30/2004US20040192746 Anticancer agents; central nervous system disorders; sexual disorders; antidiabetic agents; obesity; muscular disorders; alopecia; sepsis; autoimmune disease
09/30/2004US20040192736 New indoline compounds
09/30/2004US20040192730 Synergistic mixtures; before sex
09/30/2004US20040192685 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
09/30/2004US20040192673 Obesity, non-insulin-dependent diabetes,strokes, sleep disorders; antiischemic and antiemetic agents
09/30/2004US20040192642 Prevention of urogenital infections
09/30/2004US20040192640 Use of sucralfate for the treatment of cervical erosion
09/30/2004US20040192620 suppressing follicle maturation and ovulation and replacing the endogenous ovarian secretion of 17 beta-estradiol; 1,3,5 (10)-estratrien-3, 15 alpha ,16 alpha ,17 beta -tetrol for example; does not employ co-administration of a luteinizing hormone releasing hormone; less side effects
09/30/2004US20040192598 Composition and method of alleviating adverse side effects and/or enhancing efficacy of agents that inhibit aromatase
09/30/2004US20040192589 Production of high molecular mass lectins
09/30/2004US20040191242 Method for producing a vaccine
09/30/2004US20040191236 Administering antigen associated with disease, a dendritic cell binding agent specific for the antigen, and an autologous dendritic cell; immunotherapy
09/30/2004US20040191185 Ephedrine or fenfluramine; aluminum foil coated with a thin layer of drug is heated to form vapor; which condenses to form aerosol; rapid peak plasma concentration
09/30/2004US20040191184 Delivery of muscle relaxants through an inhalation route
09/30/2004US20040191183 Delivery of antiemetics through an inhalation route
09/30/2004US20040191182 Delivery of analgesics through an inhalation route
09/30/2004US20040191181 Vaporization of diphenhydramine from solid for breathing administerig
09/30/2004US20040191180 Breathing analgesics after vaporization for administering pain killer for headaches
09/30/2004US20040191179 Breathing antidepressants from aerosols for administering bupropion by heating on a solid support
09/30/2004CA2519444A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
09/30/2004CA2519442A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
09/30/2004CA2519440A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
09/30/2004CA2519372A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators
09/29/2004EP1462110A1 A medicine for treating woman climacteric syndrome and preparation method thereof
09/29/2004EP1462107A1 Method of female contraception and kit for use in such method
09/29/2004EP1462106A1 Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders
09/29/2004EP1461443A2 Carbohydrate-associated proteins
09/29/2004EP1461313A1 Human adam-10 inhibitors
09/29/2004EP1461122A2 Treatment of genitourinary tract disorders
09/29/2004EP1461049A1 Use of sulfated glycosaminoglycans for establishing effective labor in women
09/29/2004EP1461043A1 Oral pharmaceutical products containing 17 beta-estradiol-3 lower alkanoate, method of administering the same and process of preparation
09/29/2004EP1461023A2 Prospective identification and characterization of breast cancer stem cells
09/29/2004EP1461021A1 Transdermal drug delivery system of strychnine, brucine, securinine and their salts
09/29/2004EP1460995A1 Transdermal transport of compounds
09/29/2004EP1460969A2 Prevention and treatment of androgen-deprivation induced osteoporosis
09/29/2004EP1392700B1 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta(a)naphthalene
09/29/2004EP1351941B1 Bisaryl derivatives having fsh receptor modulatory activity
09/29/2004EP1254143B1 Lipid-based drug delivery systems
09/29/2004EP1200400B1 Substituted pyrrolidin-2,3,4-trion derivatives useful as nmda-receptor antagonists
09/29/2004EP1189905B1 Substituted heterocycle fused gamma-carbolines
09/29/2004EP1178807B1 Use of org 33245 in combined intermittent hormone therapy and contraception
09/29/2004CN1533387A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use
09/29/2004CN1533382A 哌嗪衍生物 Piperazine derivatives
09/29/2004CN1533374A Substitutled cyclohexane-1,4-diamine derivatives
09/29/2004CN1533284A Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases
09/29/2004CN1531936A Chinese medicine composition and preparation for treating pelvic inflammation of male and female and its preparing method
09/29/2004CN1168719C 6-phenylpyridyl-2-amine derivatives and pharmaceutical composition and use
09/29/2004CN1168499C Medicament for optimising mucosal viscosity and stimulating intestinal function
09/29/2004CN1168467C Medicine for treating syphilis